Stryker Capital Expenditures (CapEx) Growth & History (SYK)
Stryker's capital expenditures (capex) was $761.0M for fiscal 2025.
View full Stryker company overviewStryker annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $761.0M | $6.0M | +0.79% |
| 2024 | 2024-12-31 | $755.0M | $180.0M | +31.30% |
| 2023 | 2023-12-31 | $575.0M | −$13.0M | −2.21% |
| 2022 | 2022-12-31 | $588.0M | $63.0M | +12.00% |
| 2021 | 2021-12-31 | $525.0M | $38.0M | +7.80% |
| 2020 | 2020-12-31 | $487.0M | −$162.0M | −24.96% |
| 2019 | 2019-12-31 | $649.0M | $77.0M | +13.46% |
| 2018 | 2018-12-31 | $572.0M | −$26.0M | −4.35% |
| 2017 | 2017-12-31 | $598.0M | $108.0M | +22.04% |
| 2016 | 2016-12-31 | $490.0M | $220.0M | +81.48% |
| 2015 | 2015-12-31 | $270.0M | $37.0M | +15.88% |
| 2014 | 2014-12-31 | $233.0M | $38.0M | +19.49% |
| 2013 | 2013-12-31 | $195.0M | −$15.0M | −7.14% |
| 2012 | 2012-12-31 | $210.0M | −$16.0M | −7.08% |
| 2011 | 2011-12-31 | $226.0M | $44.0M | +24.18% |
| 2010 | 2010-12-31 | $182.0M | $51.0M | +38.93% |
| 2009 | 2009-12-31 | $131.0M | −$24.2M | −15.59% |
| 2008 | 2008-12-31 | $155.2M | −$32.5M | −17.31% |
| 2007 | 2007-12-31 | $187.7M | — | — |
Stryker quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $202.0M | $19.0M | +10.38% |
| Q1 2026 | 2026-03-31 | $166.0M | $43.0M | +34.96% |
| Q4 2025 | 2025-12-31 | $268.0M | $2.0M | +0.75% |
| Q3 2025 | 2025-09-30 | $187.0M | $17.0M | +10.00% |
| Q2 2025 | 2025-06-30 | $183.0M | $31.0M | +20.39% |
| Q1 2025 | 2025-03-31 | $123.0M | −$44.0M | −26.35% |
| Q4 2024 | 2024-12-31 | $266.0M | $121.0M | +83.45% |
| Q3 2024 | 2024-09-30 | $170.0M | $22.0M | +14.86% |
| Q2 2024 | 2024-06-30 | $152.0M | $0 | 0.00% |
| Q1 2024 | 2024-03-31 | $167.0M | $37.0M | +28.46% |
| Q4 2023 | 2023-12-31 | $145.0M | −$43.0M | −22.87% |
| Q3 2023 | 2023-09-30 | $148.0M | $10.0M | +7.25% |
| Q2 2023 | 2023-06-30 | $152.0M | $9.0M | +6.29% |
| Q1 2023 | 2023-03-31 | $130.0M | $11.0M | +9.24% |
| Q4 2022 | 2022-12-31 | $188.0M | −$18.0M | −8.74% |
| Q3 2022 | 2022-09-30 | $138.0M | $8.0M | +6.15% |
| Q2 2022 | 2022-06-30 | $143.0M | $37.0M | +34.91% |
| Q1 2022 | 2022-03-31 | $119.0M | $36.0M | +43.37% |
| Q4 2021 | 2021-12-31 | $206.0M | $41.0M | +24.85% |
| Q3 2021 | 2021-09-30 | $130.0M | $61.0M | +88.41% |
| Q2 2021 | 2021-06-30 | $106.0M | −$3.0M | −2.75% |
| Q1 2021 | 2021-03-31 | $83.0M | −$61.0M | −42.36% |
| Q4 2020 | 2020-12-31 | $165.0M | −$34.0M | −17.09% |
| Q3 2020 | 2020-09-30 | $69.0M | −$94.0M | −57.67% |
| Q2 2020 | 2020-06-30 | $109.0M | −$56.0M | −33.94% |
| Q1 2020 | 2020-03-31 | $144.0M | $22.0M | +18.03% |
| Q4 2019 | 2019-12-31 | $199.0M | $45.0M | +29.22% |
| Q3 2019 | 2019-09-30 | $163.0M | $23.0M | +16.43% |
| Q2 2019 | 2019-06-30 | $165.0M | $8.0M | +5.10% |
| Q1 2019 | 2019-03-31 | $122.0M | $1.0M | +0.83% |
| Q4 2018 | 2018-12-31 | $154.0M | −$32.0M | −17.20% |
| Q3 2018 | 2018-09-30 | $140.0M | −$2.0M | −1.41% |
| Q2 2018 | 2018-06-30 | $157.0M | $26.0M | +19.85% |
| Q1 2018 | 2018-03-31 | $121.0M | −$18.0M | −12.95% |
| Q4 2017 | 2017-12-31 | $186.0M | $43.0M | +30.07% |
| Q3 2017 | 2017-09-30 | $142.0M | $24.0M | +20.34% |
| Q2 2017 | 2017-06-30 | $131.0M | $17.0M | +14.91% |
| Q1 2017 | 2017-03-31 | $139.0M | $24.0M | +20.87% |
| Q4 2016 | 2016-12-31 | $143.0M | $64.0M | +81.01% |
| Q3 2016 | 2016-09-30 | $118.0M | $41.0M | +53.25% |
| Q2 2016 | 2016-06-30 | $114.0M | $46.0M | +67.65% |
| Q1 2016 | 2016-03-31 | $115.0M | $69.0M | +150.00% |
| Q4 2015 | 2015-12-31 | $79.0M | $18.0M | +29.51% |
| Q3 2015 | 2015-09-30 | $77.0M | $29.0M | +60.42% |
| Q2 2015 | 2015-06-30 | $68.0M | $14.0M | +25.93% |
| Q1 2015 | 2015-03-31 | $46.0M | −$24.0M | −34.29% |
| Q4 2014 | 2014-12-31 | $61.0M | $5.0M | +8.93% |
| Q3 2014 | 2014-09-30 | $48.0M | $5.0M | +11.63% |
| Q2 2014 | 2014-06-30 | $54.0M | $7.0M | +14.89% |
| Q1 2014 | 2014-03-31 | $70.0M | $21.0M | +42.86% |
| Q4 2013 | 2013-12-31 | $56.0M | $7.0M | +14.29% |
| Q3 2013 | 2013-09-30 | $43.0M | −$15.0M | −25.86% |
| Q2 2013 | 2013-06-30 | $47.0M | −$4.0M | −7.84% |
| Q1 2013 | 2013-03-31 | $49.0M | −$3.0M | −5.77% |
| Q4 2012 | 2012-12-31 | $49.0M | −$15.0M | −23.44% |
| Q3 2012 | 2012-09-30 | $58.0M | $1.0M | +1.75% |
| Q2 2012 | 2012-06-30 | $51.0M | $1.0M | +2.00% |
| Q1 2012 | 2012-03-31 | $52.0M | −$3.0M | −5.45% |
| Q4 2011 | 2011-12-31 | $64.0M | $8.5M | +15.32% |
| Q3 2011 | 2011-09-30 | $57.0M | −$1.0M | −1.72% |
| Q2 2011 | 2011-06-30 | $50.0M | $12.6M | +33.69% |
| Q1 2011 | 2011-03-31 | $55.0M | $23.9M | +76.85% |
| Q4 2010 | 2010-12-31 | $55.5M | $14.1M | +34.06% |
| Q3 2010 | 2010-09-30 | $58.0M | $29.4M | +102.80% |
| Q2 2010 | 2010-06-30 | $37.4M | $7.0M | +23.03% |
| Q1 2010 | 2010-03-31 | $31.1M | $500,000 | +1.63% |
| Q4 2009 | 2009-12-31 | $41.4M | — | — |
| Q3 2009 | 2009-09-30 | $28.6M | −$8.4M | −22.70% |
| Q2 2009 | 2009-06-30 | $30.4M | −$10.8M | −26.21% |
| Q1 2009 | 2009-03-31 | $30.6M | — | — |
| Q3 2008 | 2008-09-30 | $37.0M | — | — |
| Q2 2008 | 2008-06-30 | $41.2M | — | — |
Stryker capital expenditures (capex) trends
Over the last five fiscal years, Stryker's capital expenditures (capex) increased from $487.0M to $761.0M, a change of $274.0M. The latest reported quarter, Q2 2026, shows $202.0M.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Stryker source filings ↗Community posts
Stryker completes ZuriMED acquisition to broaden its shoulder-repair offering
Stryker ($SYK) completed its acquisition of privately held ZuriMED, adding FiberLocker technology to its sports medicine business. The commercialized product is used to augment rotator cuff repair and is designed to increase the mechanical ...